DSG3 and pemphigus: Patient classification based on anti‐Dsg1 and anti‐Dsg3 autoantibody positivity at diagnosis, regardless of pemphigus subtype and subsequent assessment of antibody titres at clinical remission, may be of use in predicting relapses.